Wellpharma

Name

Wellpharma

Legal name

Wellpharma s.r.l.

Website

https://wellpharma.it

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Pharmaceuticals & Dermatological Products

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834), Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Dermatology Specialty Pharmaceuticals (HLAIACAL)

akta.pro secondary industries

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

Keywords

• Pharmaceutical products
• Dermatological skincare
• Dietary supplements
• Medical devices
• Psoriasis treatment

Headquarters

HQ city

Iseo

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical and Health Product Sales: Wellpharma generates revenue through the sale of pharmaceutical products, cosmetics, and dietary supplements. The company manufactures and distributes its own product line including Bioprostat, Wellskin creams, Psoradin, Veractiv, and Dermamix, as well as products under sales concession arrangements such as Flaminase. Products are sold primarily through pharmacy channels in Italy.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Wellpharma is an Italian pharmaceutical company that manufactures and distributes dermatological cosmetics (Wellskin cream line), dietary supplements (Psoradin, Psoradin Microbiota, Bioprostat), medical devices (Veractiv), and emollient sprays (Dermamix), focused on dermatology, urology, and general wellness. Products are sold exclusively through Italian pharmacies via national distributor BM FARMACEUTICI, with physician and pharmacist engagement supporting patient recommendations. The portfolio combines proprietary formulations with products distributed under sales concession arrangements.

Product overview

Wellpharma is a pharmaceutical company founded in 2004 specializing in dermatology, urology, otorhinolaryngology, pneumology, orthopedics, gynecology, dentistry, and general practice products. The product portfolio includes: dietary supplements (Psoradin Microbiota, Bioprostat, Psoradin), topical cosmetics (Wellskin Crema 5, Wellskin Crema 15, Dermamix), medical devices (Veractiv), and distributed products (Flaminase). Therapeutic areas focus on dermatological conditions (psoriasis, dry skin) and urological/supplementary health. Clinical studies support Psoradin and Bioprostat products.

Differentiator

Problem solved

Functional benefit

Brands

• Wellskin: Dermatological skincare line including Wellskin Crema 5 (5% urea for hydration) and Wellskin Crema 15 (15% urea for keratolytic action), containing borage oil and vitamin E for dry, scaly skin.
• Psoradin
• Bioprostat
• Veractiv
• Flaminase
• Dermamix

Products and services

• Psoradin Microbiota Eubiotic dietary supplement containing Lactobacillus Reuteri, Lactobacillus Rhamnosus, Lactobacillus Plantarum, Vitamin B12, and folic acid. Designed to favor intestinal microbiome balance (bacterial flora) for psoriasis patients with altered microbiota at both skin and intestinal levels by addressing the gut-skin axis. Intended for adult patients with psoriasis and as adjunct therapy.
• Bioprostat Food supplement containing Vitamin D3 and isoflavones from red clover extract, packaged as a pack of 60 capsules. Contributes to normal immune system function and supports cleansing functions of the organism. Marketed for urological and prostate health support.
• Wellskin Crema 5 Hydro-lipid oil-in-water emulsion (dermatological cream) containing 5% urea, borage oil rich in gamma-linolenic acid, and Vitamin E. Indicated for dry, scaly, and reddened skin, suitable for children. Free from parabens and lanolin. Provides hydrating action for mild skin dryness.
• Wellskin Crema 15 Hydro-lipid oil-in-water emulsion (dermatological cream) containing 15% urea, borage oil, and Vitamin E, packed in 60g tubes. Features keratolytic properties for treating dry, scaly, and reddened skin. Free from parabens and lanolin. Indicated for more severe dryness and scaling conditions than Wellskin Crema 5.
• Psoradin Omega 3 dietary supplement with vitamins and minerals, packaged in 45 soft capsules. Contains linseed oil, concentrated fish oil, zinc, chromium, selenium, and Vitamins A, D3, and E. Used as adjunct therapy for psoriasis patients.
• Veractiv Classified medical device in the form of a cutaneous solution designed to facilitate the removal of warts. Sold through pharmacy channel in Italy.
• Dermamix Spray emollient for dry skin treatment, packaged in 150ml spray bottles. Indicated for pathological conditions (atopic dermatitis, eczema, ichthyosis) and physiological dry skin. Can be used as emollient/moisturizer after shower or for elderly patients.
• Flaminase Product distributed under national sales concession (concessione nazionale di vendita). Available only in pharmacy channel ('Only in chemist shop').

Quantifiable outcome

• Psoradin Microbiota addresses psoriasis symptoms by targeting altered gut and skin microbiota
• +2 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• BM FARMACEUTICIcoreChannel Partner/ Reseller/ DistributorBM FARMACEUTICI serves as the national distributor of Wellpharma products in Italy. The partnership is referenced on the Wellpharma website under Links and confirmed across multiple pages in both Italian and English versions, indicating a dedicated and established distribution relationship for the Italian market.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Galderma: Global dermatology-focused pharmaceutical and consumer skin-health company; broader and more international than Wellpharma, but relevant as the dominant incumbent in dermatology they compete against in skin conditions.
• Menarini: Large Italian pharma company with broad dermatology, gastroenterology and consumer health offerings sold via pharmacies; relevant as a broad incumbent in the same Italian distribution channels.
• Recordati: Major Italian pharmaceutical group with dermatology, urology and specialty care franchises sold through pharmacy and HCP channels; broader portfolio but overlapping therapeutic areas and Italian footprint.

Direct peers

• Istituto Ganassini: Italian dermocosmetics company with brands sold through pharmacies and parapharmacies (e.g., Rilastil, Dermoflan). Closely comparable to Wellpharma's Wellskin/Dermamix positioning in medical-grade skincare via Italian pharmacy channel.
• Giuliani SpA: Italian pharmaceutical company with a portfolio spanning dermatology, gastroenterology and specialty supplements, distributed primarily through Italian pharmacies — directly comparable therapeutic mix and GTM to Wellpharma.
• Savoma Medicinali: Italian pharmaceutical company focused on dermatology, gynecology and specialty supplements distributed via Italian pharmacies — comparable therapeutic mix and pharmacy-channel GTM.
• BIOGROUP (Biolevi & affiliates): Italian pharma group active in dietary supplements and dermatology products sold through pharmacies; comparable in product type (supplements/cosmetics) and Italian pharmacy-channel distribution.
• Difa Cooper (Cantabria Labs): Italian affiliate of Cantabria Labs distributing dermo-cosmetic and dermatology products via Italian pharmacies, with a similar HCP/detailing-led go-to-market model to Wellpharma.
• Pasquali S.r.l. Italian company selling dermatological and nutritional products through pharmacies, including probiotics and dermatology supplements — overlaps with Wellpharma's Psoradin Microbiota and Bioprostat categories.

Others

• Pierre Fabre Italia: Italian arm of Pierre Fabre Group, with dermo-cosmetics and dermatology products (e.g., Ducray, A-Derma) sold through Italian pharmacies — comparable category overlap with Wellpharma's dermatology portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/wellpharma.srl
• LinkedInlinkedin.com/company/wellpharma

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wellpharma